Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 6/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.58 |
| ▸ | HPGD | P15428 | 3/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.58 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.58 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.58 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.58 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.58 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.58 |
| ▸ | MAOA | P21397 | 1/20 | 0.58 |
| ▸ | DRD1 | P21728 | 1/20 | 0.58 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.58 |
| ▸ | HTR2B | P41595 | 1/20 | 0.58 |
| ▸ | CCR2 | P41597 | 1/20 | 0.58 |
| ▸ | CCNE2 | O96020 | 1/20 | 0.55 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.55 |
| ▸ | CDK2 | P24941 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2291745 | 1.00 | CYP1A2 (0.58) | CYP1A2ALDH1A1HSD17B10TDP1HPGD | |
| SCHEMBL30854927 | 0.97 | CYP1A2 (0.56) | CYP1A2ALDH1A1HSD17B10TDP1HPGD | |
| Naphthalene SCHEMBL6560501 | 0.97 | CYP1A2 (0.56) | CYP1A2ALDH1A1HSD17B10TDP1HPGD | |
| Benzene SCHEMBL7716364 | 0.97 | CYP1A2 (0.56) | CYP1A2ALDH1A1HSD17B10TDP1HPGD | |
| SCHEMBL28496032 | 0.97 | CYP1A2 (0.56) | CYP1A2ALDH1A1HSD17B10TDP1HPGD | |
| Benzene SCHEMBL11235066 | 0.97 | CYP1A2 (0.56) | CYP1A2ALDH1A1HSD17B10TDP1HPGD | |
| Ethylenediamine SCHEMBL27653346 | 0.89 | CCNE2 (0.51) | CYP1A2ALDH1A1HSD17B10TDP1HPGD | |
| Azobenzene SCHEMBL11130609 | 0.89 | MEN1 (0.55) | CYP1A2ALDH1A1HSD17B10TDP1HPGD | |
| Azobenzene SCHEMBL11226032 | 0.89 | MEN1 (0.55) | CYP1A2ALDH1A1HSD17B10TDP1HPGD | |
| SCHEMBL2926925 | 0.89 | MEN1 (0.55) | CYP1A2ALDH1A1HSD17B10TDP1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119725798-A | Electrolyte containing metal ion indicator, and preparation method and application thereof | 中山大学 | 2025-03-28 | — | — | CN | claimed |
| EP-0559617-A2 | Reactive dyes, method for their preparation and the use thereof | CIBA-GEIGY AG (CH) | 1993-09-08 | — | — | EP | claimed |
| US-4799960-A | JET PRINTING; METALLIZED AZO DYES; WORKABILITY IN LIQUID MEDIUM | CANON KABUSHIKI KAISHA (JP) | 1989-01-24 | — | — | US | claimed |
| US-4705528-A | Water-soluble triazine black dyes from cellulose reactive groups and suitable for use in inks | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1987-11-10 | — | — | US | claimed |
| US-20230131243-A1 | METHODS OF ATTENUATING AN IMMUNE RESPONSE BY INHIBITION OF BFL1 | CHILDREN'S HOSPITAL MEDICAL CENTER (US) | 2023-04-27 | — | — | US | disclosed |
| US-20230131243-A1 | METHODS OF ATTENUATING AN IMMUNE RESPONSE BY INHIBITION OF BFL1 | CHILDREN'S HOSPITAL MEDICAL CENTER (US) | 2023-04-27 | — | — | US | disclosed |
| US-11541073-B2 | Methods of attenuating an immune response by inhibition of BFL1 | CHILDREN'S HOSPITAL MEDICAL CENTER (US) | 2023-01-03 | — | — | US | disclosed |
| US-10995365-B2 | Compounds and systems for improving signal detection | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | 2021-05-04 | — | — | US | disclosed |
| US-20210113604-A1 | METHODS OF TREATMENT BY INHIBITION OF BFL1 | CHILDREN'S HOSPITAL MEDICAL CENTER | 2021-04-22 | — | — | US | disclosed |
| EP-3350350-B1 | COMPOUNDS AND SYSTEMS FOR IMPROVING SIGNAL DETECTION | PACIFIC BIOSCIENCES CALIFORNIA INC (US) | 2021-04-14 | — | — | EP | disclosed |
| US-10435741-B2 | Compounds and systems for improving signal detection | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2019-10-08 | — | — | US | disclosed |
| US-20190106742-A1 | COMPOUNDS AND SYSTEMS FOR IMPROVING SIGNAL DETECTION | PACIFIC BIOSCIENCES CALIFORNIA INC (US) | 2019-04-11 | — | — | US | disclosed |
| EP-0559617-A2 | Reactive dyes, method for their preparation and the use thereof | CIBA-GEIGY AG (CH) | 1993-09-08 | — | — | EP | disclosed |
| US-5241055-A | Use in cold pad-batch processing; fixing; fiber bonding; color- and washfastness; monoazo-, disazo-formazan, triphenyldioxazine and metal phthalocyanine dyes | BASF AKTIENGESELLSCHAFT (DE) | 1993-08-31 | — | — | US | disclosed |
| US-5231171-A | Dyeing or printing substrates such as cellulose | BASF AKTIENGESELLSCHAFT (DE) | 1993-07-27 | — | — | US | disclosed |
| US-5149789-A | Triazine dyes | BASF AKTIENGESELLSCHAFT (DE) | 1992-09-22 | — | — | US | disclosed |
| US-4808193-A | Process for dyeing hydroxy-containing fiber material with water-soluble dis-azo reactive dye compound | HOECHST AKTIENGESELLSCHAFT (DE) | 1989-02-28 | — | — | US | disclosed |
| US-4762916-A | CELLULOSE FABRICS | HOECHST AKTIENGESELLSCHAFT (DE) | 1988-08-09 | — | — | US | disclosed |
| US-4012369-A | METALLIZED DYES | PRODUITS CHIMIQUES UGINE KUHLMANN (FR) | 1977-03-15 | — | — | US | disclosed |
| US-4012369-A | METALLIZED DYES | PRODUITS CHIMIQUES UGINE KUHLMANN (FR) | 1977-03-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230131243-A1 | METHODS OF ATTENUATING AN IMMUNE RESPONSE BY INHIBITION OF BFL1 | CD74, IRF3, IRF2BP2 | CYP1A2 4853/4885ALDH1A1 4322/4885HSD17B10 4143/4885 |
| US-20210113604-A1 | METHODS OF TREATMENT BY INHIBITION OF BFL1 | DNASE1L3, ILF2, NCF1 | CYP1A2 4841/4885ALDH1A1 4123/4885HSD17B10 3792/4885 |
| US-11541073-B2 | Methods of attenuating an immune response by inhibition of BFL1 | CD74, IRF3, IRF2BP2 | CYP1A2 4853/4885ALDH1A1 4322/4885HSD17B10 4143/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.